Member Info for caitlin1

Huge buys coming in for this.Someone knows something.Plus directors piling in.

Coming soon from the far east.

The BBC has approached GlaxoSmithKline - original makers of Zantac. The company is reported to have stopped distributing its generic version of the drug and recalled its products from India and Hong Kong.

This will go down big time monday.Not good news.

Couldn't resist.Fantastic divi.

2 per cent up year to date .

Bought more at 2036.

 Thomas Cook's 178-year history ended in ignominy for its wealthy bosses today, who have been paid more than £20million in bonuses alone over the past five years - despite the business creaking under £1.7billion in debt and a £500million pension deficit since 2013.

Scum bags of this earth.

20 million shares to be bought back.

Thomas cook

Take over coming.

Bought a few 1000.

Oil price up 4 per cent.

Worth a buy.Book value 2.20

Smoking

Have a smoke on Brexit.

SHARE THIS ARTICLE

Share

 

Tweet

 

Post

 

Email

In this article

PM

PHILIP MORRIS IN

74.73

USD

-3.00-3.86%

MO

ALTRIA GROUP INC

46.50

USD

-0.62-1.32%

T

AT&T INC

34.78

USD

-0.15-0.43%

WFC

WELLS FARGO & CO

44.73

USD

-0.25-0.55%

CBS

CBS CORP-B

41.14

USD

-0.63-1.50%

Philip Morris International Inc., the maker of Marlboro cigarettes in overseas markets, is in talks to reunite with Altria Group Inc. more than 10 years after the tobacco giants split their operations.

Altria shares surged the most since October 2008 on the news, rising as much as 11%. Philip Morris declined as much as 11%. The deal would be the biggest since AT&T Inc. bid for Time Warner in 2016. Philip Morris had a market value of nearly $126.4 billion at the close of trading on Aug. 23, while Altria was worth about $86.7 billion.

The companies broke apart more than a decade ago, bowing to pressure from U.S. investors who wanted higher dividends and more share buybacks. The move was also pitched as a way to set free faster-growing overseas operations while the U.S. business was entangled in smoker lawsuits.

But times have changed. Altria has recently diversified its portfolio with investments in vaping and cannabis, giving the company more growth potential even as fewer people smoke cigarettes. Some analysts and investors have argued for years that the companies should get back together, a move that would give Philip Morris more U.S. exposure.

The transaction would give Philip Morris roughly 58% ownership of the new company, with Altria holding the rest, according to a person familiar with the terms who asked not to be identified because the details haven’t been made public.

They are considering a no-premium deal based on the companies’ closing share prices on Aug. 23, according to the person. The companies would aim to close the deal within six months and expect to make no divestitures, the person said.

Alternative Products

There’s been speculation that the companies might get back together. On Monday, Wells Fargo published a research note that said a deal could make sense now, in part because Altria has a stake in the vaping company Juul.

A reunification would combine two of the most popular smoking alternative products: IQOS and Juul. Philip Morris has been plowing billions of dollars in promoting IQOS, a heat-not-burn product used by millions consumers outside the U.S.. Altria meanwhile has invested $12.8 billion in e-cigarette upstart Juul Labs Inc., which has catapulted itself to the U.S. industry leader in smoking alternatives in just a few years.

Altria also has been planning to start selling IQOS in the U.S. this year, testing out demand in the Atlanta area with a store opening next month.

Philip Morris said in a statement that no agreement has been formally reached and any deal would be subject to board, shareholder and regulatory approval. Altria a

This will fly tomorrow.

Philip Morris is in talks to reunite with Marlboro maker Altria in a merger that would create a global tobacco behemoth worth more than $200bn.

The potential all-share deal with the cigarette maker, which owns the rights to Marlboro outside the US, and Altria come more than a decade after investor pressure over the threat of litigation and regulation prompted the two businesses to split.

Shares in Altria jumped more than 11pc in New York, while Philip Morris fell more than 6pc. The news also hit the share of rival tobacco firms, with British American Tobacco down 3pc.